ft 19 sep 94 lex column drug diet growth rate glaxo r amp spend deceler fast increas 25 per cent 24 per cent 1992 1993 follow budget rise 16 per cent year compani expect budget advanc 4 8 per cent 1995 part reflect glaxo develop programm complet particularli busi period slowdown also underscor gener trend last year 11 top 12 us group moder growth r amp spend three actual cut budget slacken rate r amp spend necessarili damag sector rais r amp budget unsustain level worldwid r amp invest expand dollar 5 5bn 1981 astonish dollar 30bn last year obtain return 10 per cent sum 2004 world drug market would reach dollar 448bn compar present size dollar 200bn would requir market growth 8 4 per cent year doubl present rate concern slow invest growth mean fewer innov medicin unjustifi much recent rise spend use creat worldwid develop capabl group place moreov wast pharmaceut industri legendari r amp depart among worst offend drug group rais product spend money wise fail prove incap find new medicin necessari surviv